AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
5.60
+0.69 (14.05%)
At close: Apr 14, 2026, 4:00 PM EDT
5.74
+0.14 (2.50%)
After-hours: Apr 14, 2026, 7:42 PM EDT
AVITA Medical Revenue
In the year 2025, AVITA Medical had annual revenue of $71.61M with 11.45% growth. AVITA Medical had revenue of $17.62M in the quarter ending December 31, 2025, a decrease of -4.30%.
Revenue (ttm)
$71.61M
Revenue Growth
+11.45%
P/S Ratio
2.41
Revenue / Employee
$316,858
Employees
226
Market Cap
172.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 71.61M | 7.36M | 11.45% |
| Dec 31, 2024 | 64.25M | 14.11M | 28.14% |
| Dec 31, 2023 | 50.14M | 15.72M | 45.68% |
| Dec 31, 2022 | 34.42M | 5.19M | 17.75% |
| Jun 30, 2021 | 29.23M | 14.97M | 104.95% |
| Jun 30, 2020 | 14.26M | 8.79M | 160.56% |
| Jun 30, 2019 | 5.47M | 4.55M | 489.24% |
| Jun 30, 2018 | 929.00K | - | - |
| Jun 30, 2017 | - | - | - |
| Jun 30, 2016 | - | - | - |
| Jun 30, 2015 | - | - | - |
| Jun 30, 2014 | - | - | - |
| Jun 30, 2013 | - | - | - |
| Jun 30, 2012 | - | - | - |
| Jun 30, 2011 | 4.74M | 1.45M | 44.21% |
| Jun 30, 2010 | 3.29M | 643.61K | 24.34% |
| Jun 30, 2009 | 2.64M | 768.38K | 40.97% |
| Jun 30, 2008 | 1.88M | 540.04K | 40.44% |
| Jun 30, 2007 | 1.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 348.67M |
| InfuSystem Holdings | 143.44M |
| Quanterix | 138.90M |
| Owlet | 105.71M |
| Sight Sciences | 77.36M |
| CVRx, Inc. | 56.65M |
| Apyx Medical | 52.84M |
| SANUWAVE Health | 44.05M |
RCEL News
- 12 hours ago - AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting - GlobeNewsWire
- 1 day ago - AVITA Medical, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 7 days ago - AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data - GlobeNewsWire
- 7 weeks ago - AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook - GlobeNewsWire
- 3 months ago - AVITA Medical Announces Changes to its Board of Directors - GlobeNewsWire
- 4 months ago - AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire